Of note, in cBioPortal, ATRX mutations were present in 4 (2.5%) of 162 pheochromocytomas/ paragangliomas, another tumor type that develops in NF1 patients. This evidence concerns the gene NF1 and hereditary pheochromocytoma-paraganglioma.